Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Hydrastis canadensis*, commonly known as Goldenseal, is a perennial herb in the Ranunculaceae family native to North America. It is widely utilized in traditional, herbal, and homeopathic medicine, primarily for its antimicrobial and anti-inflammatory properties. The plant's therapeutic activity is attributed to its isoquinoline alkaloids, most notably berberine and hydrastine. Homeopathic preparations, such as those manufactured by Paramesh Banerji Life Sciences, are indicated for liver ailments, digestive disorders, and mucous membrane inflammation. While it has a long history of use for conditions ranging from sinus infections to skin ulcers, *Hydrastis canadensis* products are generally classified as dietary supplements or homeopathic remedies and have not undergone formal FDA evaluation for safety or efficacy in the treatment of specific diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrastis canadensis.